US Food and Drug Administration

被引：0

作者：

Blumenthal, G. ^{[1
]}

机构：

[1] US FDA, Silver Spring, MD USA

来源：

关键词：

regulation; development; access;

D O I：

10.1016/j.jtho.2019.08.111

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ES10.01

引用

页码：S37 / S37

页数：1

共 50 条

[1] US food and drug administration
Goodman, Jesse
[J]. ONCOLOGY-NEW YORK, 2006, 20 (08): : 946 - 946
[2] US Food and Drug Administration Updates
Sahin, L.
[J]. BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 748 - 748
[3] Transparency at the US Food and Drug Administration
Califf, Robert M.
[J]. JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 24 - 28
[4] Independence at the US Food and Drug Administration
不详
[J]. LANCET, 2006, 367 (9523): : 1630 - 1630
[5] Urokinase and the US food and drug administration
Ouriel, K
[J]. JOURNAL OF VASCULAR SURGERY, 1999, 30 (05) : 957 - 958
[6] Integrated Drug Reviews at the US Food and Drug Administration
Woodcock, Janet
Stein, Peter
Bugin, Kevin
[J]. JAMA INTERNAL MEDICINE, 2020, 180 (09) : 1248 - 1250
[7] US Food and Drug Administration pushed to change
McCarthy, M
[J]. LANCET, 2006, 367 (9523): : 1643 - 1644
[8] Increasing Transparency at the US Food and Drug Administration
Steinbrook, Robert
[J]. JAMA INTERNAL MEDICINE, 2019, 179 (08) : 1146 - 1147
[9] Surgical Innovation and the US Food and Drug Administration
Cundiff, Geoffrey W.
[J]. FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2019, 25 (04): : 263 - 264
[10] The US Food and Drug Administration and Emergency Contraception
Fox, Anthony W.
[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL MEDICINE, 2005, 19 (03): : 139 - 140